WCG
ZBH icon

Weaver Consulting Group’s Zimmer Biomet ZBH Stock Holding History

Weaver Consulting Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-56
Closed -$7K – 937
2020
Q3 		$7K Hold
56
– – ﹤0.01% 645
2020
Q2 		$7K Buy
56
+13
+30% +$1.5K ﹤0.01% 617
2020
Q1 		$4K Hold
43
– – ﹤0.01% 625
2019
Q4 		$6K Buy
43
+2
+5% +$276 ﹤0.01% 587
2019
Q3 		$6K Hold
41
– – ﹤0.01% 568
2019
Q2 		$5K Hold
41
– – ﹤0.01% 600
2019
Q1 		$5K Buy
+41
New +$4.66K ﹤0.01% 1126

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Weaver Consulting Group's ZBH Position: Q4 2020 in Review

Weaver Consulting Group sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 56 shares — an estimated $7K sold.

Weaver Consulting Group first reported a position in ZBH in Q1 2019 and held it in 7 quarters. The position peaked at $7K in Q3 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Weaver Consulting Group reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 56 Zimmer Biomet shares in Q4 2020, an estimated $7K.
  • Weaver Consulting Group first reported a position in Zimmer Biomet in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Zimmer Biomet position peaked at $7K in Q3 2020.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.